glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelsberger, H; Dickfeld, T; Gawaz, M; Gebhardt, A; Neumann, FJ; Reininger, A; Schömig, A | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Myocardial Infarction
| Article | Year |
|---|---|
Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction.
Topics: Adult; Aged; Animals; Antigens, Surface; Blood Proteins; Cell Adhesion; Cells, Cultured; CHO Cells; Cricetinae; Endothelium, Vascular; Female; Humans; Intercellular Signaling Peptides and Proteins; Male; Microscopy, Electron; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Oligopeptides; Peptides; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Vitronectin; Recombinant Proteins; Umbilical Veins | 1997 |